An experienced finance and commercial executive with nearly 20 years experience at the C-Level, mostly in scientific and medical early stage companies. As a CFO he has led two successful Initial Public Offerings (IPOs) and stock exchange listings, and has extensive experience in capital raising pre and post listing, and has lead due diligence on many mergers and acquisitions including 4 across international borders.